NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Nob Hill Therapeutics

Nob Hill Therapeutics

Private
Albuquerque, New MexicoHealthcare & Life Scienceshttps://nobhilltherapeutics.com/

Last Round

Series A

Aug 6, 2024

Est. Valuation

$10M

Total Funding Raised

$6.73M

Company Overview

Nob Hill Therapeutics is a biotechnology company that develops innovative pulmonary and respiratory treatments, including its proprietary DryNeb dry powder nebulizer platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices

Business Model

B2B

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

pulmonary drug deliverydry powder nebulizerdrug-device combinationrespiratory therapeuticsinhalation technologydrug delivery deviceDryNebsmall business innovation researchSBIRinvestigational new drugINDmedtechbiotech startuprespiratory healthdrug formulation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nob Hill Therapeutics Comparables

Compare Nob Hill Therapeutics with similar companies based on industry and business-model similarity.

Nob Hill Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
InhaTarget Therapeutics
71%
AptarGroup
69%
Pulmatrix, Inc.
67%

Nob Hill Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AAug 6, 2024
GrantOct 3, 2023
GrantAug 23, 2022
SeedOct 31, 2016

Key People

Founding team and executive leadership

Noel Greenberger

Chief Executive Officer

Executive Team

Hugh Smyth

Chief Technology Officer

Executive Team

Nob Hill Therapeutics Investors

Notable investors and investment history

Nob Hill Therapeutics investors
InvestorRounds
TCA Venture GroupSeries A
VIC Technology Venture DevelopmentSeed
Tramway Venture PartnersSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 1, 2025

    Monthly visitors grew 93% MoM, reaching 1.2K.

Nob Hill Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Nob Hill Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Nob Hill Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersAlbuquerque, New Mexico
Employee Range7
Year FoundedN/A
Last FundingAug 6, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.